Thermo Fisher plans to invest USD 150 million to expand pharma services business

Thermo Fisher Scientific Inc. is investing USD 150 million in its pharma services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing. Included in the site expansion projects are Monza and Ferentino, Italy, and Greenville, North Carolina. In response to customer requests, each of the sites will be equipped with aseptic filling lines and isolator technology. Construction is expected to be completed within the next 24 months.

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.